KRASHIA, PARASKEVI
 Distribuzione geografica
Continente #
AS - Asia 1.581
NA - Nord America 181
EU - Europa 153
AF - Africa 3
SA - Sud America 2
Totale 1.920
Nazione #
SG - Singapore 1.462
US - Stati Uniti d'America 178
IT - Italia 77
CN - Cina 57
HK - Hong Kong 51
GB - Regno Unito 32
NL - Olanda 14
DE - Germania 9
FI - Finlandia 6
IN - India 5
UA - Ucraina 4
CA - Canada 3
FR - Francia 3
ZA - Sudafrica 3
AT - Austria 2
PK - Pakistan 2
BR - Brasile 1
CL - Cile 1
GR - Grecia 1
IE - Irlanda 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
PL - Polonia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.920
Città #
Singapore 55
Hong Kong 50
Rome 37
Boardman 36
Ashburn 34
London 30
Milan 29
Hefei 26
Santa Clara 19
Shanghai 19
Council Bluffs 10
Amsterdam 9
Buffalo 8
Los Angeles 8
San Francisco 5
Secaucus 5
Turku 5
Pune 4
Cave 3
Roubaix 3
Washington 3
Brooklyn 2
Charlotte 2
Hanover 2
Johannesburg 2
Nanjing 2
Redmond 2
The Dalles 2
Toronto 2
Xi'an 2
Yangzhou 2
Almere Stad 1
Bagheria 1
Bagnaria Arsa 1
Berlin 1
Bradford 1
Central 1
Changchun 1
Colombo 1
Dublin 1
Frankfurt am Main 1
Guangzhou 1
Hamburg 1
Helsinki 1
Heraklion 1
Kuala Lumpur 1
Luxembourg 1
Manchester 1
Montreal 1
Mumbai 1
New York 1
Nuremberg 1
Phoenix 1
Riga 1
Riyadh 1
St Louis 1
São Paulo 1
Waldshut-Tiengen 1
Warsaw 1
Totale 446
Nome #
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (Nature Communications, (2019), 10, 1, (3945), 10.1038/s41467-019-11928-w) 165
Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism 163
Incorporation of the β3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors 157
Cisd2: a promising new target in Alzheimer's disease† 153
Hippocampal epileptogenesis in autoimmune encephalitis. 136
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models 126
How dopamine tunes parvalbumin interneurons in the hippocampus: new experimental observations in Alzheimer's disease 101
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease 82
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice 79
Ambra1 shapes hippocampal inhibition/excitation balance: role in neurodevelopmental disorders 75
Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia. 73
Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells 70
Agonist and blocking actions of choline and tetramethylammonium on human muscle acetylcholine receptors 69
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. 68
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease 62
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 59
Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model 59
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease 46
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease 44
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases 32
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice 27
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease 27
Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer’s Disease 21
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease. 18
On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area. 17
The long activations of α2 glycine channels can be described by a mechanism with reaction intermediates ("flip") 17
Totale 1.946
Categoria #
all - tutte 9.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 0 0 0 0 0 1 8 2 0 0 19
2022/202379 0 0 54 3 3 0 0 0 1 0 18 0
2023/202490 4 11 6 12 5 44 0 0 4 2 0 2
2024/20251.747 29 6 45 10 21 42 17 31 55 138 697 656
Totale 1.946